Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Formed in 2017, Carus Animal Health is a UK-based business backed by Japan's largest animal health firm Kyoritsu Seiyaku. The new company has a mandate to stimulate innovation. Animal Pharm editor Joseph Harvey met Carus to explore its strategy for addressing unmet needs.
German firm GeneQuine Therapeutics has gained positive efficacy data for the gene therapy approach developed by the firm and Baylor College of Medicine.
Aratana Therapeutics is progressing R&D work on a candidate that targets the prostaglandin EP4 receptor.
In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.
Bayer Animal Health and NeuroCycle Therapeutics (NCT) have signed a global license agreement to bring a companion animal allergy treatment to market.
Unfenced Animal Health Experts, a division of US-based JNA Advertising, has co-compiled a report, Pet Owner Paths, alongside Merck Animal Health and Kynetec with the intention of learning more about the differences between "new school" and traditional pet owners. Animal Pharm analyst Daniel Willis met Karen Padgett, president of Unfenced, to talk about the report's findings.
Tokyo-based Sumitomo Mitsui Banking Corporation (SMBC) is to promote pet health insurance in a new agreement.
Scollar is creating the first open platform smart collar, mobile app and cloud service for multiple species.
Boehringer Ingelheim has launched Semintra, which is the first oral solution to deal with feline hypertension.
CannPal Animal Therapeutics has commenced the next phase of a pharmacokinetic and safety study for a cannabis-derived veterinary medicine to be used in pain control in dogs.
Kansas City Animal Health Investment Forum 2018 victor Torigen Pharmaceuticals has announced its intention to form partnerships within the animal health industry.
Panion Animal Health has successfully gained positive preliminary results from a safety study of its gene therapy treatment for dogs with epilepsy.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.